Despite its benefits, tirzepatide is not without risks
The trial randomized 241 patients with chronic HF with reduced left ventricular ejection fraction to receive liraglutide or placebo
These drugs are in high demand, which is causing shortages
Patients have reported decreased interest in alcohol and nicotine when taking GLP-1s, and observational studies have shown an association between treatment with GLP-1 medication and lower risk of alcohol and cannabis use disorders, opioid overdose, and alcohol-related hospitalization
I evaluate every patient personally, review their labs, and discuss realistic expectations before prescribing
This is especially helpful for people with inflammatory conditions, aiding in quicker recovery from illnesses and injuries